Xencor (XNCR) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $22.85, -4.79% vs the prior close of $24.00.
- Volume 1.13M shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
XNCR slides 4.8% to $22.85, a 1-month low. Closed at $22.85, -4.79% vs the prior close of $24.00. Day range $22.76–$24.21, opened at $24.02.
XNCR daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — XNCR slides 4.8% to $22.85, a 1-month low
- Closed at $22.85, -4.79% vs the prior close of $24.00. Day range $22.76–$24.21, opened at $24.02.
- Volume was 1.13M shares, 0.8x its 50-day average of 1.41M.
- Price is -8.7% vs its 50-day average ($25.03) and +40.1% vs its 200-day average ($16.31).
- 52-week range $10.38–$30.61; today's close sits at 62% of that range, 25.4% below the 52-week high.
Oct 15, 2026 — XNCR rises 2.6% to $24.00
- Closed at $24.00, +2.61% vs the prior close of $23.39. Day range $23.14–$24.30, opened at $23.14.
- Volume was 726.90K shares, 0.5x its 50-day average of 1.41M — lighter than usual.
- Price is -3.9% vs its 50-day average ($24.97) and +47.5% vs its 200-day average ($16.28).
- 52-week range $10.38–$30.61; today's close sits at 67% of that range, 21.6% below the 52-week high.
Oct 14, 2026 — XNCR dips 0.6% to $23.39, a 1-month low
- Closed at $23.39, -0.55% vs the prior close of $23.52. Day range $23.22–$24.26, opened at $23.43.
- Volume was 1.37M shares, 1.0x its 50-day average of 1.40M.
- Price is -6.0% vs its 50-day average ($24.89) and +44.1% vs its 200-day average ($16.23).
- 52-week range $10.38–$30.61; today's close sits at 64% of that range, 23.6% below the 52-week high.
Oct 13, 2026 — XNCR slides 6.1% to $23.52, a 1-month low
- Closed at $23.52, -6.07% vs the prior close of $25.04. Day range $23.33–$25.16, opened at $25.00.
- Volume was 2.43M shares, 1.8x its 50-day average of 1.37M.
- Price is -5.2% vs its 50-day average ($24.82) and +45.3% vs its 200-day average ($16.19).
- 52-week range $10.38–$30.61; today's close sits at 65% of that range, 23.2% below the 52-week high.
Oct 12, 2026 — XNCR rises 1.7% to $25.04, 3 up days in a row
- Closed at $25.04, +1.66% vs the prior close of $24.63. Day range $24.43–$25.32, opened at $24.64.
- Volume was 752.20K shares, 0.5x its 50-day average of 1.38M — lighter than usual.
- Price is +1.2% vs its 50-day average ($24.74) and +55.0% vs its 200-day average ($16.15).
- 52-week range $10.38–$30.61; today's close sits at 72% of that range, 18.2% below the 52-week high.
- That makes 3 straight gains.
Oct 9, 2026 — XNCR rises 0.5% to $24.63
- Closed at $24.63, +0.53% vs the prior close of $24.50. Day range $24.35–$25.38, opened at $24.43.
- Volume was 1.15M shares, 0.8x its 50-day average of 1.39M.
- Price is -0.0% vs its 50-day average ($24.64) and +53.0% vs its 200-day average ($16.10).
- 52-week range $10.38–$30.61; today's close sits at 70% of that range, 19.5% below the 52-week high.
Oct 8, 2026 — XNCR rises 1.0% to $24.50
- Closed at $24.50, +0.99% vs the prior close of $24.26. Day range $22.56–$24.56, opened at $24.02.
- Volume was 2.19M shares, 1.6x its 50-day average of 1.37M.
- Price is -0.3% vs its 50-day average ($24.58) and +52.6% vs its 200-day average ($16.06).
- 52-week range $10.38–$30.61; today's close sits at 70% of that range, 20.0% below the 52-week high.
Oct 7, 2026 — XNCR dips 0.4% to $24.26
- Closed at $24.26, -0.41% vs the prior close of $24.36. Day range $23.66–$24.59, opened at $24.11.
- Volume was 1.70M shares, 1.3x its 50-day average of 1.35M.
- Price is -0.9% vs its 50-day average ($24.48) and +51.5% vs its 200-day average ($16.01).
- 52-week range $10.38–$30.61; today's close sits at 69% of that range, 20.7% below the 52-week high.
Oct 6, 2026 — XNCR slides 5.0% to $24.36
- Closed at $24.36, -4.96% vs the prior close of $25.63. Day range $23.89–$26.03, opened at $25.76.
- Volume was 1.25M shares, 0.9x its 50-day average of 1.34M.
- Price is -0.1% vs its 50-day average ($24.39) and +52.5% vs its 200-day average ($15.97).
- 52-week range $10.38–$30.61; today's close sits at 69% of that range, 20.4% below the 52-week high.
Oct 5, 2026 — XNCR jumps 3.2% to $25.63
- Closed at $25.63, +3.18% vs the prior close of $24.84. Day range $24.83–$26.01, opened at $24.83.
- Volume was 1.28M shares, 1.0x its 50-day average of 1.33M.
- Price is +5.5% vs its 50-day average ($24.30) and +60.9% vs its 200-day average ($15.93).
- 52-week range $10.38–$30.61; today's close sits at 75% of that range, 16.3% below the 52-week high.
Oct 2, 2026 — XNCR ends flat (+0.3%) to $24.84
- Closed at $24.84, +0.28% vs the prior close of $24.77. Day range $24.14–$25.50, opened at $25.36.
- Volume was 1.10M shares, 0.8x its 50-day average of 1.32M.
- Price is +2.7% vs its 50-day average ($24.18) and +56.4% vs its 200-day average ($15.88).
- 52-week range $10.38–$30.61; today's close sits at 71% of that range, 18.9% below the 52-week high.
XNCR latest news & SEC filings
Every SEC filing by or about XNCR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 5, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $51.22M (prior year $43.61M) (+17.5% vs Jun 30, 2025)
- Net income: -$21.73M (prior year -$30.82M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.29 (prior year -$0.41) (loss narrowed vs Jun 30, 2025)
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 31, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade XNCR
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: Jul 29, 2026, May 6, 2026, Feb 25, 2026. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.21% (largest 7.6%).
- Liquidity: about 1.34M shares (≈$30.55M) trade per day on average.
- 52-week position: $22.85 vs a range of $10.38–$30.61 (62% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Ellen Feigal sold 6,843 shares on Jun 18, 2026.
- Latest filings: 10-Q Aug 5, 2026; 8-K Aug 5, 2026; 8-K Jul 29, 2026.
- Share count: 74.35M shares outstanding (Jul 31, 2026), +4.2% vs a year earlier.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
XNCR market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 24.02 | 24.21 | 22.76 | 22.85 | 1.13M |
| Oct 15, 2026 | 23.14 | 24.30 | 23.14 | 24.00 | 726.90K |
| Oct 14, 2026 | 23.43 | 24.26 | 23.22 | 23.39 | 1.37M |
| Oct 13, 2026 | 25.00 | 25.16 | 23.33 | 23.52 | 2.43M |
| Oct 12, 2026 | 24.64 | 25.32 | 24.43 | 25.04 | 752.20K |
| Oct 9, 2026 | 24.43 | 25.38 | 24.35 | 24.63 | 1.15M |
| Oct 8, 2026 | 24.02 | 24.56 | 22.56 | 24.50 | 2.19M |
| Oct 7, 2026 | 24.11 | 24.59 | 23.66 | 24.26 | 1.70M |
| Oct 6, 2026 | 25.76 | 26.03 | 23.89 | 24.36 | 1.25M |
| Oct 5, 2026 | 24.83 | 26.01 | 24.83 | 25.63 | 1.28M |
| Oct 2, 2026 | 25.36 | 25.50 | 24.14 | 24.84 | 1.10M |
| Oct 1, 2026 | 24.57 | 25.27 | 24.38 | 24.77 | 1.09M |
| Sep 30, 2026 | 25.36 | 26.35 | 24.94 | 24.95 | 1.54M |
| Sep 29, 2026 | 25.82 | 25.98 | 24.60 | 25.00 | 1.62M |
| Sep 28, 2026 | 23.90 | 25.71 | 23.74 | 25.60 | 1.53M |
| Sep 25, 2026 | 24.10 | 24.29 | 23.31 | 23.80 | 1.17M |
| Sep 24, 2026 | 24.16 | 24.69 | 23.69 | 23.88 | 952.60K |
| Sep 23, 2026 | 25.42 | 25.63 | 23.99 | 24.26 | 1.16M |
| Sep 22, 2026 | 25.08 | 25.70 | 24.86 | 25.16 | 1.22M |
| Sep 21, 2026 | 25.46 | 25.46 | 24.64 | 25.03 | 1.39M |
About Xencor
Xencor (XNCR) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in PASADENA, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1326732.
XNCR board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Bassil I Dahiyat | PRESIDENT & CEO | Mar 9, 2026 |
| Raymond Joseph Deshaies | Director | Jul 8, 2026 |
| Ellen Feigal | Director | Jul 8, 2026 |
| Kevin Charles Gorman | Director | Jul 8, 2026 |
| Kurt A Gustafson | Director | Jul 8, 2026 |
| Barbara Klencke | Director | Jul 8, 2026 |
| Alan Bruce Montgomery | Director | Jul 8, 2026 |
| Richard J Ranieri | Director | Jul 8, 2026 |
| Todd E Simpson | Director | Jul 8, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Bart Jan Cornelissen | SR. VICE PRESIDENT & CFO | Apr 13, 2026 |
| Bassil I Dahiyat | PRESIDENT & CEO | Mar 9, 2026 |
| John R Desjarlais | SR. VICE PRESIDENT & CSO | Mar 9, 2026 |
| Celia Eckert | SVP, GENERAL COUNSEL | Mar 9, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 18, 2026 | Ellen Feigal | Sale | 6,843 | $13.06 |
| Jun 18, 2026 | Ellen Feigal | Sale | 6,843 | $13.06 |
| Jun 18, 2026 | Ellen Feigal | Sale | 6,843 | $13.06 |
| Jun 18, 2026 | Ellen Feigal | Sale | 6,843 | $13.06 |
| Jun 15, 2026 | Richard J Ranieri | Sale | 5,474 | $12.31 |
| Jun 15, 2026 | Richard J Ranieri | Sale | 5,474 | $12.31 |
| Jun 15, 2026 | Richard J Ranieri | Sale | 5,474 | $12.31 |
| Jun 15, 2026 | Richard J Ranieri | Sale | 5,474 | $12.31 |
| Jun 15, 2026 | Kurt A Gustafson | Sale | 5,474 | $12.31 |
| Jun 15, 2026 | Kurt A Gustafson | Sale | 5,474 | $12.31 |
| Jun 15, 2026 | Kurt A Gustafson | Sale | 5,474 | $12.31 |
| Jun 15, 2026 | Kurt A Gustafson | Sale | 5,474 | $12.31 |
| Jun 15, 2026 | Kevin Charles Gorman | Sale | 7,527 | $12.31 |
| Jun 15, 2026 | Kevin Charles Gorman | Sale | 7,527 | $12.31 |
| Jun 15, 2026 | Kevin Charles Gorman | Sale | 7,527 | $12.31 |
XNCR financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $125.58M | $-91.92M | -1.24 | $-135.12M |
| Dec 31, 2024 | $110.49M | $-232.62M | -3.58 | $-202.19M |
| Dec 31, 2023 | $174.62M | $-133.13M | -2.20 | $-77.93M |
| Dec 31, 2022 | $164.58M | $-55.18M | -0.93 | $24.48M |
| Dec 31, 2021 | $275.11M | $82.63M | 1.37 | $-16.85M |
Latest balance sheet: total assets $724.96M, total liabilities $221.73M, cash $44.66M (as of Jun 30, 2026).
XNCR earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $19.84 |
| Jul 29, 2026 | 8-K Item 2.02 (results) | $19.53 |
| May 6, 2026 | 8-K Item 2.02 (results) | $13.01 |
| Feb 25, 2026 | 8-K Item 2.02 (results) | $11.98 |
| Jan 8, 2026 | 8-K Item 2.02 (results) | $14.19 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $14.37 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $7.49 |
| May 7, 2025 | 8-K Item 2.02 (results) | $7.99 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $14.98 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $20.26 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $22.68 |
| Aug 5, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on XNCR
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.